Home › Atrial Fibrillation › Virginia › Richmond
Atrial Fibrillation clinical trials in Richmond, VA
5 studies for Atrial Fibrillation are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- James River Cardiology, Richmond
- Virginia Commonwealth University, Richmond
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
RecruitingObservational study
- CJW Medical Center, Richmond
- Bon Secours St. Marys, Midlothian · 11 mi away
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Bon Secours St. Mary's Hospital, Richmond
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
RecruitingObservational study
- Virginia Commonwealth University, Richmond
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RecruitingObservational study
- Bon Secours Medical Group - Richmond Specialty Care, Richmond
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Boston, MA17 studies
- Cleveland, OH17 studies
- Atlanta, GA16 studies
- Philadelphia, PA12 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Ann Arbor, MI11 studies
- Cincinnati, OH10 studies
- Pittsburgh, PA10 studies
- Columbus, OH10 studies
- New Orleans, LA9 studies
Other studies in Richmond
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer25 studies
- Prostate Cancer19 studies
- Heart Failure16 studies
- Lung Cancer14 studies
- Cardiovascular Disease13 studies
- Colorectal Cancer13 studies
- Steatotic Liver Disease12 studies
- Acute Myeloid Leukemia12 studies
- Metastatic Cancer12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Obesity11 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.